Macerich Financials
0JX5 Stock | 19.97 0.34 1.73% |
Operating Margin 0.1371 | PE Ratio 1.044 | Profit Margin 0.1006 | Payout Ratio 0.3779 | Return On Equity 0.0348 |
Macerich | Select Account or Indicator |
Understanding current and past Macerich Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Macerich's financial statements are interrelated, with each one affecting the others. For example, an increase in Macerich's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Macerich's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Macerich Co. Check Macerich's Beneish M Score to see the likelihood of Macerich's management manipulating its earnings.
Macerich Stock Summary
Macerich competes with Bellevue Healthcare, Naturhouse Health, Public Storage, Automatic Data, and Cardinal Health. Macerich is entity of United Kingdom. It is traded as Stock on LSE exchange.Specialization | Industrials, Commercial & Professional Services |
Instrument | UK Stock View All |
Exchange | London Exchange |
Business Address | 401 Wilshire Boulevard, |
Sector | Commercial Services & Supplies |
Industry | Industrials |
Benchmark | Dow Jones Industrial |
Website | www.macerich.com |
Phone | 310 394 6000 |
You should never invest in Macerich without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Macerich Stock, because this is throwing your money away. Analyzing the key information contained in Macerich's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Macerich Key Financial Ratios
There are many critical financial ratios that Macerich's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Macerich reports annually and quarterly.Revenue | 881.37 M | |||
Gross Profit | 475.16 M | |||
EBITDA | 190.72 M | |||
Net Income | (274.06 M) | |||
Total Asset | 7.51 B |
Macerich Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 8.9B | 9.2B | 8.3B | 8.1B | 7.5B | 7.1B | |
Net Debt | 14.2M | 5.7B | 4.5B | 4.4B | 4.2B | 3.7B | |
Retained Earnings | (1.9B) | (2.3B) | (2.4B) | (2.6B) | (3.1B) | (2.9B) | |
Other Assets | 221.3M | 212.0M | 179.5M | 174.4M | 7.5B | 7.9B | |
Total Liab | 6.0B | 6.7B | 5.2B | 5.1B | 5.0B | 4.7B | |
Other Current Liab | 373.5M | 407.0M | 382.2M | 439.8M | 1.2B | 1.3B | |
Accounts Payable | 51.0M | 68.8M | 59.2M | 63.1M | 64.2M | 73.9M | |
Cash | 100.0M | 465.3M | 112.5M | 100.3M | 94.9M | 117.6M | |
Net Receivables | 150.2M | 240.8M | 211.4M | 186.9M | 188.2M | 129.6M | |
Total Current Assets | 264.4M | 1.0B | 633.2M | 368.0M | 378.5M | 450.5M | |
Common Stock | 1.4M | 1.5M | 2.1M | 2.2M | 2.2M | 1.2M | |
Other Current Assets | 14.2M | 17.4M | 254.9M | 80.8M | 95.4M | 101.7M | |
Inventory | 46.6M | 278.6M | 17.4M | 54.5M | 62.7M | 71.4M | |
Intangible Assets | 158.6M | 175.5M | 151.8M | 152.6M | 65.4M | 62.1M | |
Long Term Debt | 5.2B | 5.4B | 5.5B | 6.2B | 7.1B | 6.0B | |
Good Will | 30.8M | 30.8M | 23.4M | 23.1M | 24.0M | 23.2M | |
Capital Surpluse | 4.5B | 4.6B | 4.6B | 4.6B | 5.3B | 5.0B | |
Short Term Debt | 327.2M | 2.1B | 813.3M | 603.8M | 823.1M | 1.0B | |
Other Liab | 37.1M | 71.1M | 53.8M | 48.4M | 43.5M | 43.7M | |
Net Tangible Assets | 2.6B | 2.2B | 3.0B | 2.8B | 2.5B | 2.2B |
Macerich Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Revenue | 927.5M | 786.0M | 847.4M | 859.2M | 881.4M | 737.9M | |
Gross Profit | 559.5M | 438.0M | 466.6M | 468.8M | 204.1M | 193.9M | |
Operating Income | 254.7M | (102.2M) | 141.1M | 144.8M | 177.6M | 201.4M | |
Ebit | (59.3M) | (402.7M) | (278.9M) | (296.3M) | (105.7M) | (100.4M) | |
Ebitda | 585.4M | 155.7M | 452.2M | 436.4M | 190.7M | 181.2M | |
Net Income | 96.8M | (245.5M) | 14.3M | (65.1M) | (274.1M) | (260.4M) | |
Income Tax Expense | 1.6M | (447K) | 6.9M | 705K | (494K) | (469.3K) | |
Interest Expense | 138.3M | 75.6M | 192.7M | 216.9M | 172.9M | 147.6M | |
Income Before Tax | 104.1M | (245.9M) | 23.1M | (64.4M) | (273.6M) | (259.9M) | |
Cost Of Revenue | 368.0M | 348.0M | 380.9M | 390.4M | 677.3M | 368.2M | |
Tax Provision | 1.4M | (3.6M) | 1.6M | (447K) | (402.3K) | (382.2K) | |
Interest Income | 85.5M | 71.8M | 48.5M | 27.0M | 24.3M | 46.4M | |
Research Development | 0.12 | 0.21 | 0.16 | 0.06 | 0.08 | 0.1 |
Macerich Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change In Cash | (35.1M) | 368.4M | (315.7M) | 14.2M | 9.2M | 9.6M | |
Free Cash Flow | 355.2M | 124.8M | 286.4M | 337.5M | 295.5M | 310.3M | |
Depreciation | 332.5M | 324.0M | 322.5M | 300.3M | 296.4M | 242.6M | |
Other Non Cash Items | (76.2M) | 123.2M | (127.1M) | 79.1M | 242.2M | 254.3M | |
Capital Expenditures | 21.1M | 23.1M | 110.9M | 97.9M | 159.5M | 265.7M | |
Net Income | 96.8M | (230.2M) | 14.3M | (66.1M) | (274.1M) | (260.4M) | |
End Period Cash Flow | 114.2M | 482.7M | 167.0M | 181.1M | 190.3M | 121.7M | |
Change To Inventory | (23.8M) | (12.3M) | 40.2M | 17.9M | 16.1M | 17.0M | |
Dividends Paid | 424.3M | 165.4M | 118.3M | 133.3M | 146.6M | 289.6M | |
Investments | 13.4M | (54.0M) | 7.1M | 70.6M | 63.5M | 72.4M | |
Net Borrowings | 199.5M | 628.6M | (1.5B) | (131.0M) | (117.9M) | (123.8M) | |
Change To Netincome | (94.7M) | 138.9M | (94.8M) | 42.9M | 49.4M | 51.8M |
Macerich Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Macerich's current stock value. Our valuation model uses many indicators to compare Macerich value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Macerich competition to find correlations between indicators driving Macerich's intrinsic value. More Info.Macerich Co is rated fifth in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about 0.17 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Macerich Co is roughly 5.90 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Macerich's earnings, one of the primary drivers of an investment's value.Macerich Systematic Risk
Macerich's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Macerich volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Macerich correlated with the market. If Beta is less than 0 Macerich generally moves in the opposite direction as compared to the market. If Macerich Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Macerich is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Macerich is generally in the same direction as the market. If Beta > 1 Macerich moves generally in the same direction as, but more than the movement of the benchmark.
Macerich Co Total Assets Over Time
Macerich November 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Macerich help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Macerich Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Macerich Co based on widely used predictive technical indicators. In general, we focus on analyzing Macerich Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Macerich's daily price indicators and compare them against related drivers.
Downside Deviation | 2.06 | |||
Information Ratio | 0.1658 | |||
Maximum Drawdown | 9.36 | |||
Value At Risk | (3.45) | |||
Potential Upside | 3.36 |
Additional Tools for Macerich Stock Analysis
When running Macerich's price analysis, check to measure Macerich's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Macerich is operating at the current time. Most of Macerich's value examination focuses on studying past and present price action to predict the probability of Macerich's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Macerich's price. Additionally, you may evaluate how the addition of Macerich to your portfolios can decrease your overall portfolio volatility.